SCHEMBL5367600

SCHEMBL5367600

Cc1cc(C=C2C(=O)Nc3ccc(CCCl)cc32)cc(C)c1OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 4/20 0.53
PSEN1 P49768 3/20 0.44
PSEN2 P49810 3/20 0.44
APH1B Q8WW43 3/20 0.44
NCSTN Q92542 3/20 0.44
APH1A Q96BI3 3/20 0.44
PSENEN Q9NZ42 3/20 0.44
MAOA P21397 3/20 0.43
MAOB P27338 3/20 0.43
RAF1 P04049 1/20 0.42
PPARG P37231 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
FLT3 P36888 2/20 0.41
SIRT2 Q8IXJ6 2/20 0.41
SIRT1 Q96EB6 1/20 0.40
SIRT3 Q9NTG7 1/20 0.40
SIRT5 Q9NXA8 1/20 0.40
PLK4 O00444 1/20 0.40
PLK1 P53350 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5358637 0.87 ERBB2 (0.51) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL5366802 0.86 LRRK2 (0.70) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL7139020 0.85 PSEN1 (0.61) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL5376624 0.84 ERBB2 (0.50) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL5358813 0.84 ERBB2 (0.47) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL5370370 0.84 ERBB2 (0.58) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL7138836 0.83 MAOA (0.51) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL5361803 0.83 LRRK2 (0.65) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL5368689 0.82 LRRK2 (0.69) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL7133928 0.81 LRRK2 (0.53) LRRK2PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK LRRK2 289/4885PSEN1 3695/4885PSEN2 3641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.